Rik Haagmans
Overview
Explore the profile of Rik Haagmans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haagmans R, Charity O, Baker D, Telatin A, Savva G, Adriaenssens E, et al.
Viruses
. 2025 Feb;
17(2).
PMID: 40006910
Whole transcriptome amplification (WTA2) and sequence-independent single primer amplification (SISPA) are two widely used methods for combined metagenomic sequencing of RNA and DNA viruses. However, information on the reproducibility and...
2.
Seton K, Espejo-Oltra J, Gimenez-Orenga K, Haagmans R, Ramadan D, Mehlsen J
J Clin Med
. 2024 Jan;
13(2).
PMID: 38256459
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic, debilitating, and multi-faceted illness. Heterogenous onset and clinical presentation with additional comorbidities make it difficult to diagnose, characterize, and successfully treat. Current...
3.
Filina O, Demirbas B, Haagmans R, van Zon J
Proc Natl Acad Sci U S A
. 2022 Jun;
119(26):e2206338119.
PMID: 35733254
No abstract available.
4.
Filina O, Demirbas B, Haagmans R, van Zon J
Proc Natl Acad Sci U S A
. 2022 Mar;
119(11):e2123110119.
PMID: 35263226
SignificanceAn enduring mystery of development is how its timing is controlled, particularly for development after birth, where timing is highly flexible and depends on environmental conditions, such as food availability...
5.
Tariq M, Newberry F, Haagmans R, Booth C, Wileman T, Hoyles L, et al.
Front Microbiol
. 2020 Nov;
11:583378.
PMID: 33193224
spp. are part of the human intestinal microbiota but can under some circumstances become clinical pathogens. Phages are a potentially valuable therapeutic treatment option for many pathogens, but phage therapy...